Retaglutide is a innovative GLP-1 receptor agonist currently under investigation for the management of type 2 diabetes. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally https://kianarcrm227433.bluxeblog.com/71152331/retaglutide-a-promising-glp-1-receptor-agonist